FILE PHOTO: A well being employee attracts a dose of Pfizer-BioNTech coronavirus illness (COVID-19) vaccine from a vial throughout a vaccination occasion hosted by Miami – Dade County and Miami Warmth, at FTX Enviornment in Miami, Florida, U.S., August 5, 2021. REUTERS/Marco Bello/File Photograph
August 30, 2021
By Praveen Menon
WELLINGTON (Reuters) -New Zealand reported its first recorded dying linked to U.S. drugmaker Pfizer’s COVID-19 vaccine, the well being ministry stated on Monday, after a lady suffered a uncommon facet impact resulting in irritation of her coronary heart muscle.
The information of the dying comes because the nation battles an outbreak of the Delta variant after almost six months of being virus free. It adopted a evaluation by an impartial panel monitoring the security of the vaccines.
“That is the primary case in New Zealand the place a dying within the days following vaccination has been linked to the Pfizer COVID-19 vaccine,” the ministry stated in a press release, with out giving the girl’s age.
The vaccine monitoring panel attributed the dying to myocarditis, a uncommon, however identified, facet impact of the Pfizer vaccine, the ministry added.
Myocarditis is an irritation of the center muscle that may restrict the organ’s potential to pump blood and may trigger modifications in heartbeat rhythms.
In response, Pfizer stated it recognised there may very well be uncommon studies of myocarditis after vaccinations, however such unwanted effects have been extraordinarily uncommon.
“Pfizer takes opposed occasions which can be doubtlessly related to our vaccine very significantly,” it instructed Reuters.
“We carefully monitor all such occasions and acquire related info to share with worldwide regulatory authorities.”
The well being ministry stated different medical points on the similar time might have influenced the end result after vaccination.
However the vaccine’s profit outstripped dangers from unwanted effects, it added.
“The advantages of vaccination with the Pfizer COVID-19 vaccine proceed to vastly outweigh the chance of each COVID-19 an infection and vaccine unwanted effects, together with myocarditis.”
New Zealand has provisionally authorized use of the Pfizer/BioNTech, Janssen and AstraZeneca vaccines, however solely the Pfizer produced vaccine has been authorized for rollout to the general public.
Monday’s 53 new instances took New Zealand’s tally of infections within the present outbreak to 562, amid a nationwide lockdown enforced this month to restrict unfold of the Delta variant.
(Reporting by Praveen Menon; Modifying by Christian Schmollinger and Clarence Fernandez)